Networked Scanners
PRODUCTS
-
The AMP20078 is a solid-state, high-power amplifier from Exodus Advanced Communication, purpose-built for EMI/RFI testing, laboratory work, continuous wave (CW), pulse, and communication applications across a broad frequency spectrum.
-
A powerful and agile intuitive EQMS
ETQ Reliance® is a leading-edge eQMS (Electronic Quality Management System) software designed to centralize and automate quality processes across enterprises. -
The full-service Contract Research Organization (CRO) with operations in Australia, New Zealand, Asia, North America, and Europe.
-
Powerful And Comprehensive Cell Culture Profiling
Cedex Bio HT Analyzer - the right instrument for improved workflow efficiency
- High throughput: Numerous samples can be processed simultaneously with minimal manual intervention
- Long-term operation: Long time on-board stability of reagents and assay cal
- Flexible dilution: Automated sample dilution capabilities save time and accuracy
- Full automation: Online integration with automated systems to optimize measurement points and timelines
- Enhanced flexibility with the 96-well upgrade kit
-
The Future of Precision Medicine: Radiopharmaceutical Preparation for Targeted Diagnostics and Treatment
Safer and More Effective Radiopharmaceutical Production With Germfree's Advanced Cleanrooms and Equipment Solutions
Radiopharmaceuticals are drugs that contain radioactive isotopes and are used as diagnostic and therapeutic agents. Due to the hazardous nature of radioisotopes, lead shielded aseptic processing equipment is required for their production and handling. These cleanrooms have specific requirements such as HEPA exhaust and biosecurity features to prevent contamination and protect workers.
Germfree’s expertise in designing facilities and equipment for complex critical environments ensures compliant radiopharmaceutical preparation and production at varying scales. Radiopharmaceuticals play a crucial role in advanced therapies, including nuclear medicine and cancer treatment, and are a rapidly growing sector of the biopharmaceutical industry.
WHITE PAPERS AND CASE STUDIES
-
Bispecific Antibodies Unleashed
Explore how leveraging expert CDMO partnerships can streamline the development process and enhance the efficacy of your bispecific antibody therapies.
-
Generation Of A Contamination Control Strategy
An unaddressed compliance issue related to contamination control can pose a significant risk to a life sciences organization. This case study details a company's journey toward sustainable compliance.
-
Forge Boosts Efficiency And Compliance During External Collaboration
Streamlined collaboration and unified quality systems are helping CDMOs cut review times. Discover how connected workflows improve compliance and efficiency for faster delivery of life-changing treatments.
-
Immunogenicity Risk Assessment In Drug Candidate Selection
Identify and address potential anti-drug immune responses early in development to streamline your drug’s path to clinical success—start smart and finish fast.
-
Effective Recruitment Capabilities And Outstanding Customer Service
Hear from many customers who commend OpenClinica's effective recruitment capabilities, outstanding customer service, and adept problem resolution.
-
Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance
Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.
-
Vibration Compensated OCXOs: Advantages, Disadvantages, And Market Applications
Electronically compensated and mechanically isolated OCXOs each offer unique benefits for vibration-sensitive applications; choosing the right design depends on size, power, and performance requirements.
-
AAV-Based Gene Editing For Huntington's Disease
LETI-101 uses AAV5 to deliver a compact CRISPR system for allele-selective editing of mutant HTT, showing promise as a one-time treatment for Huntington’s disease with strong preclinical safety and efficacy.
-
Leading Recruitment With A Strong Alzheimer's Referral Pool And Clean Data
A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.
-
Owen Mumford Slashes Audit Findings, CAPAs, And NCRs
Gain insights into how Owen Mumford, a global medical device leader, enhanced their compliance and efficiency with software to reduce audit findings and improve quality management.
-
Successful Cell-Based ADA Collaboration In mRNA Gene Replacement Therapy
A biotech firm developed a rapid, sensitive, cell-based ADA assay through collaborative innovation, reducing variability and turnaround time while improving performance for mRNA gene therapy.
-
Optimizing Upstream Process Development To Increase mAb Titers
Uncover how we were able to help a client develop an efficient upstream process for a novel monoclonal antibody (mAb), resulting in a more than 100% increase in titers.
NEWS
-
AbTherx And Dragonfly Therapeutics Expand Antibody Discovery Partnership9/23/2025
AbTherx, a biotechnology company pioneering technologies that accelerate antibody discovery, today announced an expansion of its ongoing partnership with Dragonfly Therapeutics (Dragonfly) following a successful multi-target pilot study comparing transgenic platforms.
-
SGD Pharma Leads Pharma Packaging Innovation And Decarbonization At PharmaPack Europe 20261/28/2026
SGD Pharma, a global market leader in pharmaceutical glass primary packaging and the leader of its industry on sustainability, will showcase its latest advancements in high-performance solutions at Pharmapack Europe, taking place in Paris on 21st to 22nd January 2026.
-
Wood Secures $120M Engineering Contract Extension With Shell UK2/20/2025
John Wood Group PLC (‘Wood’ or ‘the Company’) has been awarded a $120M contract extension by Shell UK Limited to provide brownfield engineering, procurement and construction (EPC) to onshore and offshore assets across the UK.
-
Artificio Processes Documents In 80+ Languages, Enabling Multinational Corporations To Automate Global Operations12/9/2025
Artificio Products Inc., a leader in AI-powered intelligent document processing and enterprise workflow automation, today announced that its platform now processes documents in more than 80 languages, positioning the company as a comprehensive solution for multinational corporations managing cross-border document operations.
-
Simbe Expands Next-Generation Computer Vision Technology To Transform Retail Execution5/20/2025
Simbe, the global leader in shelf digitization, today announced significant advancements to Simbe Vision™, its AI-powered computer vision (CV) technology, further solidifying the company's position as the retail industry's most advanced in-store intelligence solution.